Gastric Cancer-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2124654, encodeId=c2562124654db, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：分子;肿瘤;基础 经验分享：一审一个多月，两个审稿人很专业，给了两个月时间 major revision。二审十天，minor revision 当天修回后三天accept。 编辑的效率非常高，submit后第二天就with editor，隔天就under review。非常不错的杂志，影响因子和声誉都在稳步上升。 目前发文量减少，还是以临床文章为主，缺乏优质的基础研究，希望越办越好。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=153, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e5015158554, createdName=146afc57m84暂无昵称, createdTime=Sun Apr 09 22:11:45 CST 2023, time=2023-04-09, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=584929, encodeId=023f584929cd, content=打印出来签名150****6011暂无昵称 2020-02-13 00:00:00 发表: 你好，请问你的certification form 怎么填写的啊, beContent=150****6011暂无昵称 2020-02-13 00:00:00 发表: 你好，请问你的certification form 怎么填写的啊, objectType=tool_impact_factor, channel=null, level=null, likeNumber=205, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=55925271857, createdName=148249d5m16暂无昵称, createdTime=Tue Feb 18 00:00:00 CST 2020, time=2020-02-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=849606, encodeId=99ad84960665, content=审稿速度较快，但是对临床的部分要求严格。给了大修意见，二审四天接收。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=158, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4e0b5414039, createdName=ms9688259418763462, createdTime=Sun Feb 03 07:34:23 CST 2019, time=2019-02-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1237773, encodeId=30f6123e77310, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：6.20投稿，7.10意见回来，8.9日返回，8.10 收到acceptance email～审稿速度，和editor 的速度，意外的快……本来以为修回后，可能会等一段时间，结果，第二天早上就收到email~ 很有效率, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=04935553570, createdName=cyfy1112@163.com, createdTime=Wed Aug 10 09:49:50 CST 2022, time=2022-08-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=570704, encodeId=7c095e07046f, content=它收纳肝癌相关的文章吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=153, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/22/0ddfb5f93bf4092dfab0f122ddd93d58.jpg, createdBy=e5902208056, createdName=120cc505m10(暂无昵称), createdTime=Thu May 09 23:30:00 CST 2019, time=2019-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1182349, encodeId=348e1182349cf, content=大神们，小麻瓜想问，这个杂志需不需要提供知情同意书哇，感谢。审稿快不快哇，着急毕业哇。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220410/72abed6ca19c4aca86961c1291a3a3c6/e23fe3265bd64221b9f3d1f39f00a99f.jpg, createdBy=6a3e5632321, createdName=ms6000000933123975, createdTime=Sat Jan 08 21:34:03 CST 2022, time=2022-01-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584675, encodeId=30ff5846e5ef, content=你好，请问你的certification form 怎么填写的啊173HkaH1982(暂无昵称) 2020-02-10 00:00:00 发表: 我都这个状态2个月了，怎么办, beContent=173HkaH1982(暂无昵称) 2020-02-10 00:00:00 发表: 我都这个状态2个月了，怎么办, objectType=tool_impact_factor, channel=null, level=null, likeNumber=210, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=82e95278898, createdName=1483b6d8m11暂无昵称, createdTime=Thu Feb 13 00:00:00 CST 2020, time=2020-02-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1101679, encodeId=49ee11016e91e, content=什么是letter?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Tue Dec 28 14:52:51 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1101680, encodeId=abce110168050, content=什么是comment？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Wed Dec 29 14:52:51 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584504, encodeId=e7f0584504f6, content=我都这个状态2个月了，怎么办158****5936暂无昵称 2020-02-05 00:00:00 发表: under review, beContent=158****5936暂无昵称 2020-02-05 00:00:00 发表: under review, objectType=tool_impact_factor, channel=null, level=null, likeNumber=170, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e6715139146, createdName=146715bem82(暂无昵称), createdTime=Mon Feb 10 00:00:00 CST 2020, time=2020-02-10, status=1, ipAttribution=)]

2023-04-09 146afc57m84暂无昵称来自江苏省

审稿速度:2.0 | 投稿命中率:50.0
偏重的研究方向：分子;肿瘤;基础
经验分享：一审一个多月，两个审稿人很专业，给了两个月时间 major revision。二审十天，minor revision 当天修回后三天accept。
编辑的效率非常高，submit后第二天就with editor，隔天就under review。非常不错的杂志，影响因子和声誉都在稳步上升。
目前发文量减少，还是以临床文章为主，缺乏优质的基础研究，希望越办越好。

153 7

展开7条回复

[GetPortalCommentsPageByObjectIdResponse(id=2124654, encodeId=c2562124654db, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：分子;肿瘤;基础 经验分享：一审一个多月，两个审稿人很专业，给了两个月时间 major revision。二审十天，minor revision 当天修回后三天accept。 编辑的效率非常高，submit后第二天就with editor，隔天就under review。非常不错的杂志，影响因子和声誉都在稳步上升。 目前发文量减少，还是以临床文章为主，缺乏优质的基础研究，希望越办越好。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=153, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e5015158554, createdName=146afc57m84暂无昵称, createdTime=Sun Apr 09 22:11:45 CST 2023, time=2023-04-09, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=584929, encodeId=023f584929cd, content=打印出来签名150****6011暂无昵称 2020-02-13 00:00:00 发表: 你好，请问你的certification form 怎么填写的啊, beContent=150****6011暂无昵称 2020-02-13 00:00:00 发表: 你好，请问你的certification form 怎么填写的啊, objectType=tool_impact_factor, channel=null, level=null, likeNumber=205, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=55925271857, createdName=148249d5m16暂无昵称, createdTime=Tue Feb 18 00:00:00 CST 2020, time=2020-02-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=849606, encodeId=99ad84960665, content=审稿速度较快，但是对临床的部分要求严格。给了大修意见，二审四天接收。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=158, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4e0b5414039, createdName=ms9688259418763462, createdTime=Sun Feb 03 07:34:23 CST 2019, time=2019-02-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1237773, encodeId=30f6123e77310, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：6.20投稿，7.10意见回来，8.9日返回，8.10 收到acceptance email～审稿速度，和editor 的速度，意外的快……本来以为修回后，可能会等一段时间，结果，第二天早上就收到email~ 很有效率, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=04935553570, createdName=cyfy1112@163.com, createdTime=Wed Aug 10 09:49:50 CST 2022, time=2022-08-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=570704, encodeId=7c095e07046f, content=它收纳肝癌相关的文章吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=153, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/22/0ddfb5f93bf4092dfab0f122ddd93d58.jpg, createdBy=e5902208056, createdName=120cc505m10(暂无昵称), createdTime=Thu May 09 23:30:00 CST 2019, time=2019-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1182349, encodeId=348e1182349cf, content=大神们，小麻瓜想问，这个杂志需不需要提供知情同意书哇，感谢。审稿快不快哇，着急毕业哇。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220410/72abed6ca19c4aca86961c1291a3a3c6/e23fe3265bd64221b9f3d1f39f00a99f.jpg, createdBy=6a3e5632321, createdName=ms6000000933123975, createdTime=Sat Jan 08 21:34:03 CST 2022, time=2022-01-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584675, encodeId=30ff5846e5ef, content=你好，请问你的certification form 怎么填写的啊173HkaH1982(暂无昵称) 2020-02-10 00:00:00 发表: 我都这个状态2个月了，怎么办, beContent=173HkaH1982(暂无昵称) 2020-02-10 00:00:00 发表: 我都这个状态2个月了，怎么办, objectType=tool_impact_factor, channel=null, level=null, likeNumber=210, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=82e95278898, createdName=1483b6d8m11暂无昵称, createdTime=Thu Feb 13 00:00:00 CST 2020, time=2020-02-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1101679, encodeId=49ee11016e91e, content=什么是letter?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Tue Dec 28 14:52:51 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1101680, encodeId=abce110168050, content=什么是comment？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Wed Dec 29 14:52:51 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584504, encodeId=e7f0584504f6, content=我都这个状态2个月了，怎么办158****5936暂无昵称 2020-02-05 00:00:00 发表: under review, beContent=158****5936暂无昵称 2020-02-05 00:00:00 发表: under review, objectType=tool_impact_factor, channel=null, level=null, likeNumber=170, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e6715139146, createdName=146715bem82(暂无昵称), createdTime=Mon Feb 10 00:00:00 CST 2020, time=2020-02-10, status=1, ipAttribution=)]

2020-02-18 148249d5m16暂无昵称

打印出来签名150****6011暂无昵称 2020-02-13 00:00:00 发表:
你好，请问你的certification form 怎么填写的啊

150****6011暂无昵称 2020-02-13 00:00:00 发表: 你好，请问你的certification form 怎么填写的啊

205 4

展开4条回复

[GetPortalCommentsPageByObjectIdResponse(id=2124654, encodeId=c2562124654db, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：分子;肿瘤;基础 经验分享：一审一个多月，两个审稿人很专业，给了两个月时间 major revision。二审十天，minor revision 当天修回后三天accept。 编辑的效率非常高，submit后第二天就with editor，隔天就under review。非常不错的杂志，影响因子和声誉都在稳步上升。 目前发文量减少，还是以临床文章为主，缺乏优质的基础研究，希望越办越好。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=153, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e5015158554, createdName=146afc57m84暂无昵称, createdTime=Sun Apr 09 22:11:45 CST 2023, time=2023-04-09, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=584929, encodeId=023f584929cd, content=打印出来签名150****6011暂无昵称 2020-02-13 00:00:00 发表: 你好，请问你的certification form 怎么填写的啊, beContent=150****6011暂无昵称 2020-02-13 00:00:00 发表: 你好，请问你的certification form 怎么填写的啊, objectType=tool_impact_factor, channel=null, level=null, likeNumber=205, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=55925271857, createdName=148249d5m16暂无昵称, createdTime=Tue Feb 18 00:00:00 CST 2020, time=2020-02-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=849606, encodeId=99ad84960665, content=审稿速度较快，但是对临床的部分要求严格。给了大修意见，二审四天接收。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=158, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4e0b5414039, createdName=ms9688259418763462, createdTime=Sun Feb 03 07:34:23 CST 2019, time=2019-02-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1237773, encodeId=30f6123e77310, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：6.20投稿，7.10意见回来，8.9日返回，8.10 收到acceptance email～审稿速度，和editor 的速度，意外的快……本来以为修回后，可能会等一段时间，结果，第二天早上就收到email~ 很有效率, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=04935553570, createdName=cyfy1112@163.com, createdTime=Wed Aug 10 09:49:50 CST 2022, time=2022-08-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=570704, encodeId=7c095e07046f, content=它收纳肝癌相关的文章吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=153, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/22/0ddfb5f93bf4092dfab0f122ddd93d58.jpg, createdBy=e5902208056, createdName=120cc505m10(暂无昵称), createdTime=Thu May 09 23:30:00 CST 2019, time=2019-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1182349, encodeId=348e1182349cf, content=大神们，小麻瓜想问，这个杂志需不需要提供知情同意书哇，感谢。审稿快不快哇，着急毕业哇。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220410/72abed6ca19c4aca86961c1291a3a3c6/e23fe3265bd64221b9f3d1f39f00a99f.jpg, createdBy=6a3e5632321, createdName=ms6000000933123975, createdTime=Sat Jan 08 21:34:03 CST 2022, time=2022-01-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584675, encodeId=30ff5846e5ef, content=你好，请问你的certification form 怎么填写的啊173HkaH1982(暂无昵称) 2020-02-10 00:00:00 发表: 我都这个状态2个月了，怎么办, beContent=173HkaH1982(暂无昵称) 2020-02-10 00:00:00 发表: 我都这个状态2个月了，怎么办, objectType=tool_impact_factor, channel=null, level=null, likeNumber=210, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=82e95278898, createdName=1483b6d8m11暂无昵称, createdTime=Thu Feb 13 00:00:00 CST 2020, time=2020-02-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1101679, encodeId=49ee11016e91e, content=什么是letter?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Tue Dec 28 14:52:51 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1101680, encodeId=abce110168050, content=什么是comment？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Wed Dec 29 14:52:51 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584504, encodeId=e7f0584504f6, content=我都这个状态2个月了，怎么办158****5936暂无昵称 2020-02-05 00:00:00 发表: under review, beContent=158****5936暂无昵称 2020-02-05 00:00:00 发表: under review, objectType=tool_impact_factor, channel=null, level=null, likeNumber=170, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e6715139146, createdName=146715bem82(暂无昵称), createdTime=Mon Feb 10 00:00:00 CST 2020, time=2020-02-10, status=1, ipAttribution=)]

2019-02-03 ms9688259418763462

审稿速度较快，但是对临床的部分要求严格。给了大修意见，二审四天接收。

158 4

展开4条回复

[GetPortalCommentsPageByObjectIdResponse(id=2124654, encodeId=c2562124654db, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：分子;肿瘤;基础 经验分享：一审一个多月，两个审稿人很专业，给了两个月时间 major revision。二审十天，minor revision 当天修回后三天accept。 编辑的效率非常高，submit后第二天就with editor，隔天就under review。非常不错的杂志，影响因子和声誉都在稳步上升。 目前发文量减少，还是以临床文章为主，缺乏优质的基础研究，希望越办越好。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=153, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e5015158554, createdName=146afc57m84暂无昵称, createdTime=Sun Apr 09 22:11:45 CST 2023, time=2023-04-09, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=584929, encodeId=023f584929cd, content=打印出来签名150****6011暂无昵称 2020-02-13 00:00:00 发表: 你好，请问你的certification form 怎么填写的啊, beContent=150****6011暂无昵称 2020-02-13 00:00:00 发表: 你好，请问你的certification form 怎么填写的啊, objectType=tool_impact_factor, channel=null, level=null, likeNumber=205, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=55925271857, createdName=148249d5m16暂无昵称, createdTime=Tue Feb 18 00:00:00 CST 2020, time=2020-02-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=849606, encodeId=99ad84960665, content=审稿速度较快，但是对临床的部分要求严格。给了大修意见，二审四天接收。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=158, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4e0b5414039, createdName=ms9688259418763462, createdTime=Sun Feb 03 07:34:23 CST 2019, time=2019-02-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1237773, encodeId=30f6123e77310, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：6.20投稿，7.10意见回来，8.9日返回，8.10 收到acceptance email～审稿速度，和editor 的速度，意外的快……本来以为修回后，可能会等一段时间，结果，第二天早上就收到email~ 很有效率, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=04935553570, createdName=cyfy1112@163.com, createdTime=Wed Aug 10 09:49:50 CST 2022, time=2022-08-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=570704, encodeId=7c095e07046f, content=它收纳肝癌相关的文章吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=153, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/22/0ddfb5f93bf4092dfab0f122ddd93d58.jpg, createdBy=e5902208056, createdName=120cc505m10(暂无昵称), createdTime=Thu May 09 23:30:00 CST 2019, time=2019-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1182349, encodeId=348e1182349cf, content=大神们，小麻瓜想问，这个杂志需不需要提供知情同意书哇，感谢。审稿快不快哇，着急毕业哇。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220410/72abed6ca19c4aca86961c1291a3a3c6/e23fe3265bd64221b9f3d1f39f00a99f.jpg, createdBy=6a3e5632321, createdName=ms6000000933123975, createdTime=Sat Jan 08 21:34:03 CST 2022, time=2022-01-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584675, encodeId=30ff5846e5ef, content=你好，请问你的certification form 怎么填写的啊173HkaH1982(暂无昵称) 2020-02-10 00:00:00 发表: 我都这个状态2个月了，怎么办, beContent=173HkaH1982(暂无昵称) 2020-02-10 00:00:00 发表: 我都这个状态2个月了，怎么办, objectType=tool_impact_factor, channel=null, level=null, likeNumber=210, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=82e95278898, createdName=1483b6d8m11暂无昵称, createdTime=Thu Feb 13 00:00:00 CST 2020, time=2020-02-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1101679, encodeId=49ee11016e91e, content=什么是letter?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Tue Dec 28 14:52:51 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1101680, encodeId=abce110168050, content=什么是comment？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Wed Dec 29 14:52:51 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584504, encodeId=e7f0584504f6, content=我都这个状态2个月了，怎么办158****5936暂无昵称 2020-02-05 00:00:00 发表: under review, beContent=158****5936暂无昵称 2020-02-05 00:00:00 发表: under review, objectType=tool_impact_factor, channel=null, level=null, likeNumber=170, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e6715139146, createdName=146715bem82(暂无昵称), createdTime=Mon Feb 10 00:00:00 CST 2020, time=2020-02-10, status=1, ipAttribution=)]

2022-08-10 cyfy1112@163.com

审稿速度:1.0 | 投稿命中率:75.0
经验分享：6.20投稿，7.10意见回来，8.9日返回，8.10 收到acceptance email～审稿速度，和editor 的速度，意外的快……本来以为修回后，可能会等一段时间，结果，第二天早上就收到email~
很有效率

99 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2124654, encodeId=c2562124654db, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：分子;肿瘤;基础 经验分享：一审一个多月，两个审稿人很专业，给了两个月时间 major revision。二审十天，minor revision 当天修回后三天accept。 编辑的效率非常高，submit后第二天就with editor，隔天就under review。非常不错的杂志，影响因子和声誉都在稳步上升。 目前发文量减少，还是以临床文章为主，缺乏优质的基础研究，希望越办越好。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=153, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e5015158554, createdName=146afc57m84暂无昵称, createdTime=Sun Apr 09 22:11:45 CST 2023, time=2023-04-09, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=584929, encodeId=023f584929cd, content=打印出来签名150****6011暂无昵称 2020-02-13 00:00:00 发表: 你好，请问你的certification form 怎么填写的啊, beContent=150****6011暂无昵称 2020-02-13 00:00:00 发表: 你好，请问你的certification form 怎么填写的啊, objectType=tool_impact_factor, channel=null, level=null, likeNumber=205, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=55925271857, createdName=148249d5m16暂无昵称, createdTime=Tue Feb 18 00:00:00 CST 2020, time=2020-02-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=849606, encodeId=99ad84960665, content=审稿速度较快，但是对临床的部分要求严格。给了大修意见，二审四天接收。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=158, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4e0b5414039, createdName=ms9688259418763462, createdTime=Sun Feb 03 07:34:23 CST 2019, time=2019-02-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1237773, encodeId=30f6123e77310, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：6.20投稿，7.10意见回来，8.9日返回，8.10 收到acceptance email～审稿速度，和editor 的速度，意外的快……本来以为修回后，可能会等一段时间，结果，第二天早上就收到email~ 很有效率, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=04935553570, createdName=cyfy1112@163.com, createdTime=Wed Aug 10 09:49:50 CST 2022, time=2022-08-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=570704, encodeId=7c095e07046f, content=它收纳肝癌相关的文章吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=153, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/22/0ddfb5f93bf4092dfab0f122ddd93d58.jpg, createdBy=e5902208056, createdName=120cc505m10(暂无昵称), createdTime=Thu May 09 23:30:00 CST 2019, time=2019-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1182349, encodeId=348e1182349cf, content=大神们，小麻瓜想问，这个杂志需不需要提供知情同意书哇，感谢。审稿快不快哇，着急毕业哇。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220410/72abed6ca19c4aca86961c1291a3a3c6/e23fe3265bd64221b9f3d1f39f00a99f.jpg, createdBy=6a3e5632321, createdName=ms6000000933123975, createdTime=Sat Jan 08 21:34:03 CST 2022, time=2022-01-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584675, encodeId=30ff5846e5ef, content=你好，请问你的certification form 怎么填写的啊173HkaH1982(暂无昵称) 2020-02-10 00:00:00 发表: 我都这个状态2个月了，怎么办, beContent=173HkaH1982(暂无昵称) 2020-02-10 00:00:00 发表: 我都这个状态2个月了，怎么办, objectType=tool_impact_factor, channel=null, level=null, likeNumber=210, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=82e95278898, createdName=1483b6d8m11暂无昵称, createdTime=Thu Feb 13 00:00:00 CST 2020, time=2020-02-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1101679, encodeId=49ee11016e91e, content=什么是letter?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Tue Dec 28 14:52:51 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1101680, encodeId=abce110168050, content=什么是comment？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Wed Dec 29 14:52:51 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584504, encodeId=e7f0584504f6, content=我都这个状态2个月了，怎么办158****5936暂无昵称 2020-02-05 00:00:00 发表: under review, beContent=158****5936暂无昵称 2020-02-05 00:00:00 发表: under review, objectType=tool_impact_factor, channel=null, level=null, likeNumber=170, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e6715139146, createdName=146715bem82(暂无昵称), createdTime=Mon Feb 10 00:00:00 CST 2020, time=2020-02-10, status=1, ipAttribution=)]

2019-05-09 120cc505m10(暂无昵称)

它收纳肝癌相关的文章吗？

153 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2124654, encodeId=c2562124654db, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：分子;肿瘤;基础 经验分享：一审一个多月，两个审稿人很专业，给了两个月时间 major revision。二审十天，minor revision 当天修回后三天accept。 编辑的效率非常高，submit后第二天就with editor，隔天就under review。非常不错的杂志，影响因子和声誉都在稳步上升。 目前发文量减少，还是以临床文章为主，缺乏优质的基础研究，希望越办越好。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=153, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e5015158554, createdName=146afc57m84暂无昵称, createdTime=Sun Apr 09 22:11:45 CST 2023, time=2023-04-09, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=584929, encodeId=023f584929cd, content=打印出来签名150****6011暂无昵称 2020-02-13 00:00:00 发表: 你好，请问你的certification form 怎么填写的啊, beContent=150****6011暂无昵称 2020-02-13 00:00:00 发表: 你好，请问你的certification form 怎么填写的啊, objectType=tool_impact_factor, channel=null, level=null, likeNumber=205, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=55925271857, createdName=148249d5m16暂无昵称, createdTime=Tue Feb 18 00:00:00 CST 2020, time=2020-02-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=849606, encodeId=99ad84960665, content=审稿速度较快，但是对临床的部分要求严格。给了大修意见，二审四天接收。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=158, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4e0b5414039, createdName=ms9688259418763462, createdTime=Sun Feb 03 07:34:23 CST 2019, time=2019-02-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1237773, encodeId=30f6123e77310, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：6.20投稿，7.10意见回来，8.9日返回，8.10 收到acceptance email～审稿速度，和editor 的速度，意外的快……本来以为修回后，可能会等一段时间，结果，第二天早上就收到email~ 很有效率, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=04935553570, createdName=cyfy1112@163.com, createdTime=Wed Aug 10 09:49:50 CST 2022, time=2022-08-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=570704, encodeId=7c095e07046f, content=它收纳肝癌相关的文章吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=153, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/22/0ddfb5f93bf4092dfab0f122ddd93d58.jpg, createdBy=e5902208056, createdName=120cc505m10(暂无昵称), createdTime=Thu May 09 23:30:00 CST 2019, time=2019-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1182349, encodeId=348e1182349cf, content=大神们，小麻瓜想问，这个杂志需不需要提供知情同意书哇，感谢。审稿快不快哇，着急毕业哇。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220410/72abed6ca19c4aca86961c1291a3a3c6/e23fe3265bd64221b9f3d1f39f00a99f.jpg, createdBy=6a3e5632321, createdName=ms6000000933123975, createdTime=Sat Jan 08 21:34:03 CST 2022, time=2022-01-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584675, encodeId=30ff5846e5ef, content=你好，请问你的certification form 怎么填写的啊173HkaH1982(暂无昵称) 2020-02-10 00:00:00 发表: 我都这个状态2个月了，怎么办, beContent=173HkaH1982(暂无昵称) 2020-02-10 00:00:00 发表: 我都这个状态2个月了，怎么办, objectType=tool_impact_factor, channel=null, level=null, likeNumber=210, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=82e95278898, createdName=1483b6d8m11暂无昵称, createdTime=Thu Feb 13 00:00:00 CST 2020, time=2020-02-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1101679, encodeId=49ee11016e91e, content=什么是letter?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Tue Dec 28 14:52:51 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1101680, encodeId=abce110168050, content=什么是comment？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Wed Dec 29 14:52:51 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584504, encodeId=e7f0584504f6, content=我都这个状态2个月了，怎么办158****5936暂无昵称 2020-02-05 00:00:00 发表: under review, beContent=158****5936暂无昵称 2020-02-05 00:00:00 发表: under review, objectType=tool_impact_factor, channel=null, level=null, likeNumber=170, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e6715139146, createdName=146715bem82(暂无昵称), createdTime=Mon Feb 10 00:00:00 CST 2020, time=2020-02-10, status=1, ipAttribution=)]

2022-01-08 ms6000000933123975

大神们，小麻瓜想问，这个杂志需不需要提供知情同意书哇，感谢。审稿快不快哇，着急毕业哇。

109 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2124654, encodeId=c2562124654db, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：分子;肿瘤;基础 经验分享：一审一个多月，两个审稿人很专业，给了两个月时间 major revision。二审十天，minor revision 当天修回后三天accept。 编辑的效率非常高，submit后第二天就with editor，隔天就under review。非常不错的杂志，影响因子和声誉都在稳步上升。 目前发文量减少，还是以临床文章为主，缺乏优质的基础研究，希望越办越好。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=153, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e5015158554, createdName=146afc57m84暂无昵称, createdTime=Sun Apr 09 22:11:45 CST 2023, time=2023-04-09, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=584929, encodeId=023f584929cd, content=打印出来签名150****6011暂无昵称 2020-02-13 00:00:00 发表: 你好，请问你的certification form 怎么填写的啊, beContent=150****6011暂无昵称 2020-02-13 00:00:00 发表: 你好，请问你的certification form 怎么填写的啊, objectType=tool_impact_factor, channel=null, level=null, likeNumber=205, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=55925271857, createdName=148249d5m16暂无昵称, createdTime=Tue Feb 18 00:00:00 CST 2020, time=2020-02-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=849606, encodeId=99ad84960665, content=审稿速度较快，但是对临床的部分要求严格。给了大修意见，二审四天接收。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=158, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4e0b5414039, createdName=ms9688259418763462, createdTime=Sun Feb 03 07:34:23 CST 2019, time=2019-02-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1237773, encodeId=30f6123e77310, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：6.20投稿，7.10意见回来，8.9日返回，8.10 收到acceptance email～审稿速度，和editor 的速度，意外的快……本来以为修回后，可能会等一段时间，结果，第二天早上就收到email~ 很有效率, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=04935553570, createdName=cyfy1112@163.com, createdTime=Wed Aug 10 09:49:50 CST 2022, time=2022-08-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=570704, encodeId=7c095e07046f, content=它收纳肝癌相关的文章吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=153, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/22/0ddfb5f93bf4092dfab0f122ddd93d58.jpg, createdBy=e5902208056, createdName=120cc505m10(暂无昵称), createdTime=Thu May 09 23:30:00 CST 2019, time=2019-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1182349, encodeId=348e1182349cf, content=大神们，小麻瓜想问，这个杂志需不需要提供知情同意书哇，感谢。审稿快不快哇，着急毕业哇。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220410/72abed6ca19c4aca86961c1291a3a3c6/e23fe3265bd64221b9f3d1f39f00a99f.jpg, createdBy=6a3e5632321, createdName=ms6000000933123975, createdTime=Sat Jan 08 21:34:03 CST 2022, time=2022-01-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584675, encodeId=30ff5846e5ef, content=你好，请问你的certification form 怎么填写的啊173HkaH1982(暂无昵称) 2020-02-10 00:00:00 发表: 我都这个状态2个月了，怎么办, beContent=173HkaH1982(暂无昵称) 2020-02-10 00:00:00 发表: 我都这个状态2个月了，怎么办, objectType=tool_impact_factor, channel=null, level=null, likeNumber=210, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=82e95278898, createdName=1483b6d8m11暂无昵称, createdTime=Thu Feb 13 00:00:00 CST 2020, time=2020-02-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1101679, encodeId=49ee11016e91e, content=什么是letter?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Tue Dec 28 14:52:51 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1101680, encodeId=abce110168050, content=什么是comment？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Wed Dec 29 14:52:51 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584504, encodeId=e7f0584504f6, content=我都这个状态2个月了，怎么办158****5936暂无昵称 2020-02-05 00:00:00 发表: under review, beContent=158****5936暂无昵称 2020-02-05 00:00:00 发表: under review, objectType=tool_impact_factor, channel=null, level=null, likeNumber=170, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e6715139146, createdName=146715bem82(暂无昵称), createdTime=Mon Feb 10 00:00:00 CST 2020, time=2020-02-10, status=1, ipAttribution=)]

2020-02-13 1483b6d8m11暂无昵称

你好，请问你的certification form 怎么填写的啊173HkaH1982(暂无昵称) 2020-02-10 00:00:00 发表:
我都这个状态2个月了，怎么办

173HkaH1982(暂无昵称) 2020-02-10 00:00:00 发表: 我都这个状态2个月了，怎么办

210 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2124654, encodeId=c2562124654db, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：分子;肿瘤;基础 经验分享：一审一个多月，两个审稿人很专业，给了两个月时间 major revision。二审十天，minor revision 当天修回后三天accept。 编辑的效率非常高，submit后第二天就with editor，隔天就under review。非常不错的杂志，影响因子和声誉都在稳步上升。 目前发文量减少，还是以临床文章为主，缺乏优质的基础研究，希望越办越好。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=153, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e5015158554, createdName=146afc57m84暂无昵称, createdTime=Sun Apr 09 22:11:45 CST 2023, time=2023-04-09, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=584929, encodeId=023f584929cd, content=打印出来签名150****6011暂无昵称 2020-02-13 00:00:00 发表: 你好，请问你的certification form 怎么填写的啊, beContent=150****6011暂无昵称 2020-02-13 00:00:00 发表: 你好，请问你的certification form 怎么填写的啊, objectType=tool_impact_factor, channel=null, level=null, likeNumber=205, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=55925271857, createdName=148249d5m16暂无昵称, createdTime=Tue Feb 18 00:00:00 CST 2020, time=2020-02-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=849606, encodeId=99ad84960665, content=审稿速度较快，但是对临床的部分要求严格。给了大修意见，二审四天接收。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=158, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4e0b5414039, createdName=ms9688259418763462, createdTime=Sun Feb 03 07:34:23 CST 2019, time=2019-02-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1237773, encodeId=30f6123e77310, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：6.20投稿，7.10意见回来，8.9日返回，8.10 收到acceptance email～审稿速度，和editor 的速度，意外的快……本来以为修回后，可能会等一段时间，结果，第二天早上就收到email~ 很有效率, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=04935553570, createdName=cyfy1112@163.com, createdTime=Wed Aug 10 09:49:50 CST 2022, time=2022-08-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=570704, encodeId=7c095e07046f, content=它收纳肝癌相关的文章吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=153, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/22/0ddfb5f93bf4092dfab0f122ddd93d58.jpg, createdBy=e5902208056, createdName=120cc505m10(暂无昵称), createdTime=Thu May 09 23:30:00 CST 2019, time=2019-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1182349, encodeId=348e1182349cf, content=大神们，小麻瓜想问，这个杂志需不需要提供知情同意书哇，感谢。审稿快不快哇，着急毕业哇。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220410/72abed6ca19c4aca86961c1291a3a3c6/e23fe3265bd64221b9f3d1f39f00a99f.jpg, createdBy=6a3e5632321, createdName=ms6000000933123975, createdTime=Sat Jan 08 21:34:03 CST 2022, time=2022-01-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584675, encodeId=30ff5846e5ef, content=你好，请问你的certification form 怎么填写的啊173HkaH1982(暂无昵称) 2020-02-10 00:00:00 发表: 我都这个状态2个月了，怎么办, beContent=173HkaH1982(暂无昵称) 2020-02-10 00:00:00 发表: 我都这个状态2个月了，怎么办, objectType=tool_impact_factor, channel=null, level=null, likeNumber=210, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=82e95278898, createdName=1483b6d8m11暂无昵称, createdTime=Thu Feb 13 00:00:00 CST 2020, time=2020-02-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1101679, encodeId=49ee11016e91e, content=什么是letter?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Tue Dec 28 14:52:51 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1101680, encodeId=abce110168050, content=什么是comment？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Wed Dec 29 14:52:51 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584504, encodeId=e7f0584504f6, content=我都这个状态2个月了，怎么办158****5936暂无昵称 2020-02-05 00:00:00 发表: under review, beContent=158****5936暂无昵称 2020-02-05 00:00:00 发表: under review, objectType=tool_impact_factor, channel=null, level=null, likeNumber=170, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e6715139146, createdName=146715bem82(暂无昵称), createdTime=Mon Feb 10 00:00:00 CST 2020, time=2020-02-10, status=1, ipAttribution=)]

2021-12-28 Mia

什么是letter?

70 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2124654, encodeId=c2562124654db, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：分子;肿瘤;基础 经验分享：一审一个多月，两个审稿人很专业，给了两个月时间 major revision。二审十天，minor revision 当天修回后三天accept。 编辑的效率非常高，submit后第二天就with editor，隔天就under review。非常不错的杂志，影响因子和声誉都在稳步上升。 目前发文量减少，还是以临床文章为主，缺乏优质的基础研究，希望越办越好。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=153, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e5015158554, createdName=146afc57m84暂无昵称, createdTime=Sun Apr 09 22:11:45 CST 2023, time=2023-04-09, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=584929, encodeId=023f584929cd, content=打印出来签名150****6011暂无昵称 2020-02-13 00:00:00 发表: 你好，请问你的certification form 怎么填写的啊, beContent=150****6011暂无昵称 2020-02-13 00:00:00 发表: 你好，请问你的certification form 怎么填写的啊, objectType=tool_impact_factor, channel=null, level=null, likeNumber=205, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=55925271857, createdName=148249d5m16暂无昵称, createdTime=Tue Feb 18 00:00:00 CST 2020, time=2020-02-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=849606, encodeId=99ad84960665, content=审稿速度较快，但是对临床的部分要求严格。给了大修意见，二审四天接收。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=158, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4e0b5414039, createdName=ms9688259418763462, createdTime=Sun Feb 03 07:34:23 CST 2019, time=2019-02-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1237773, encodeId=30f6123e77310, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：6.20投稿，7.10意见回来，8.9日返回，8.10 收到acceptance email～审稿速度，和editor 的速度，意外的快……本来以为修回后，可能会等一段时间，结果，第二天早上就收到email~ 很有效率, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=04935553570, createdName=cyfy1112@163.com, createdTime=Wed Aug 10 09:49:50 CST 2022, time=2022-08-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=570704, encodeId=7c095e07046f, content=它收纳肝癌相关的文章吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=153, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/22/0ddfb5f93bf4092dfab0f122ddd93d58.jpg, createdBy=e5902208056, createdName=120cc505m10(暂无昵称), createdTime=Thu May 09 23:30:00 CST 2019, time=2019-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1182349, encodeId=348e1182349cf, content=大神们，小麻瓜想问，这个杂志需不需要提供知情同意书哇，感谢。审稿快不快哇，着急毕业哇。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220410/72abed6ca19c4aca86961c1291a3a3c6/e23fe3265bd64221b9f3d1f39f00a99f.jpg, createdBy=6a3e5632321, createdName=ms6000000933123975, createdTime=Sat Jan 08 21:34:03 CST 2022, time=2022-01-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584675, encodeId=30ff5846e5ef, content=你好，请问你的certification form 怎么填写的啊173HkaH1982(暂无昵称) 2020-02-10 00:00:00 发表: 我都这个状态2个月了，怎么办, beContent=173HkaH1982(暂无昵称) 2020-02-10 00:00:00 发表: 我都这个状态2个月了，怎么办, objectType=tool_impact_factor, channel=null, level=null, likeNumber=210, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=82e95278898, createdName=1483b6d8m11暂无昵称, createdTime=Thu Feb 13 00:00:00 CST 2020, time=2020-02-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1101679, encodeId=49ee11016e91e, content=什么是letter?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Tue Dec 28 14:52:51 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1101680, encodeId=abce110168050, content=什么是comment？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Wed Dec 29 14:52:51 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584504, encodeId=e7f0584504f6, content=我都这个状态2个月了，怎么办158****5936暂无昵称 2020-02-05 00:00:00 发表: under review, beContent=158****5936暂无昵称 2020-02-05 00:00:00 发表: under review, objectType=tool_impact_factor, channel=null, level=null, likeNumber=170, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e6715139146, createdName=146715bem82(暂无昵称), createdTime=Mon Feb 10 00:00:00 CST 2020, time=2020-02-10, status=1, ipAttribution=)]

2021-12-29 Gym璨烨

什么是comment？

101 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2124654, encodeId=c2562124654db, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：分子;肿瘤;基础 经验分享：一审一个多月，两个审稿人很专业，给了两个月时间 major revision。二审十天，minor revision 当天修回后三天accept。 编辑的效率非常高，submit后第二天就with editor，隔天就under review。非常不错的杂志，影响因子和声誉都在稳步上升。 目前发文量减少，还是以临床文章为主，缺乏优质的基础研究，希望越办越好。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=153, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e5015158554, createdName=146afc57m84暂无昵称, createdTime=Sun Apr 09 22:11:45 CST 2023, time=2023-04-09, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=584929, encodeId=023f584929cd, content=打印出来签名150****6011暂无昵称 2020-02-13 00:00:00 发表: 你好，请问你的certification form 怎么填写的啊, beContent=150****6011暂无昵称 2020-02-13 00:00:00 发表: 你好，请问你的certification form 怎么填写的啊, objectType=tool_impact_factor, channel=null, level=null, likeNumber=205, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=55925271857, createdName=148249d5m16暂无昵称, createdTime=Tue Feb 18 00:00:00 CST 2020, time=2020-02-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=849606, encodeId=99ad84960665, content=审稿速度较快，但是对临床的部分要求严格。给了大修意见，二审四天接收。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=158, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4e0b5414039, createdName=ms9688259418763462, createdTime=Sun Feb 03 07:34:23 CST 2019, time=2019-02-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1237773, encodeId=30f6123e77310, content=审稿速度:1.0 | 投稿命中率:75.0 经验分享：6.20投稿，7.10意见回来，8.9日返回，8.10 收到acceptance email～审稿速度，和editor 的速度，意外的快……本来以为修回后，可能会等一段时间，结果，第二天早上就收到email~ 很有效率, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=04935553570, createdName=cyfy1112@163.com, createdTime=Wed Aug 10 09:49:50 CST 2022, time=2022-08-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=570704, encodeId=7c095e07046f, content=它收纳肝癌相关的文章吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=153, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/22/0ddfb5f93bf4092dfab0f122ddd93d58.jpg, createdBy=e5902208056, createdName=120cc505m10(暂无昵称), createdTime=Thu May 09 23:30:00 CST 2019, time=2019-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1182349, encodeId=348e1182349cf, content=大神们，小麻瓜想问，这个杂志需不需要提供知情同意书哇，感谢。审稿快不快哇，着急毕业哇。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=109, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220410/72abed6ca19c4aca86961c1291a3a3c6/e23fe3265bd64221b9f3d1f39f00a99f.jpg, createdBy=6a3e5632321, createdName=ms6000000933123975, createdTime=Sat Jan 08 21:34:03 CST 2022, time=2022-01-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584675, encodeId=30ff5846e5ef, content=你好，请问你的certification form 怎么填写的啊173HkaH1982(暂无昵称) 2020-02-10 00:00:00 发表: 我都这个状态2个月了，怎么办, beContent=173HkaH1982(暂无昵称) 2020-02-10 00:00:00 发表: 我都这个状态2个月了，怎么办, objectType=tool_impact_factor, channel=null, level=null, likeNumber=210, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=82e95278898, createdName=1483b6d8m11暂无昵称, createdTime=Thu Feb 13 00:00:00 CST 2020, time=2020-02-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1101679, encodeId=49ee11016e91e, content=什么是letter?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=70, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Tue Dec 28 14:52:51 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1101680, encodeId=abce110168050, content=什么是comment？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Wed Dec 29 14:52:51 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584504, encodeId=e7f0584504f6, content=我都这个状态2个月了，怎么办158****5936暂无昵称 2020-02-05 00:00:00 发表: under review, beContent=158****5936暂无昵称 2020-02-05 00:00:00 发表: under review, objectType=tool_impact_factor, channel=null, level=null, likeNumber=170, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e6715139146, createdName=146715bem82(暂无昵称), createdTime=Mon Feb 10 00:00:00 CST 2020, time=2020-02-10, status=1, ipAttribution=)]

2020-02-10 146715bem82(暂无昵称)

我都这个状态2个月了，怎么办158****5936暂无昵称 2020-02-05 00:00:00 发表:
under review

158****5936暂无昵称 2020-02-05 00:00:00 发表: under review

170 1

展开1条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务